330 related articles for article (PubMed ID: 11521175)
21. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.
Nejak-Bowen K
Gene Expr; 2020 Jun; 20(1):19-23. PubMed ID: 31439080
[TBL] [Abstract][Full Text] [Related]
22. Vanishing bile duct disorders.
Desmet VJ
Prog Liver Dis; 1992; 10():89-121. PubMed ID: 1296239
[No Abstract] [Full Text] [Related]
23. Cholangiocyte injury and ductopenic syndromes.
Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
[TBL] [Abstract][Full Text] [Related]
24. Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey.
Kobayashi S; Nakanuma Y; Matsui O
Hum Pathol; 1994 Sep; 25(9):940-6. PubMed ID: 8088771
[TBL] [Abstract][Full Text] [Related]
25. Histopathology of chronic cholestasis and adult ductopenic syndrome.
Desmet VJ
Clin Liver Dis; 1998 May; 2(2):249-64, viii. PubMed ID: 15560031
[TBL] [Abstract][Full Text] [Related]
26. Marked diffuse dilations of the biliary tree associated with intrahepatic calculi, biliary sludges and a mucinous cyst of the pancreatic head in a 99-year-old woman.
Terada T; Terai T; Yamawaki T
Pathol Int; 2003 Aug; 53(8):563-8. PubMed ID: 12895237
[TBL] [Abstract][Full Text] [Related]
27. Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology.
Sasaki M; Tsuneyama K; Saito T; Kataoka H; Mollenhauer J; Poustka A; Nakanuma Y
Liver Int; 2004 Feb; 24(1):29-37. PubMed ID: 15101998
[TBL] [Abstract][Full Text] [Related]
28. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study.
Tsuneyama K; Harada K; Yasoshima M; Kaji K; Gershwin ME; Nakanuma Y
J Pathol; 1998 Oct; 186(2):126-30. PubMed ID: 9924426
[TBL] [Abstract][Full Text] [Related]
29. Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia.
Nakanuma Y; Harada K; Sato Y; Ikeda H
Histol Histopathol; 2010 Feb; 25(2):223-35. PubMed ID: 20017109
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
Graham RP; Smyrk TC; Zhang L
Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
[TBL] [Abstract][Full Text] [Related]
31. Intrahepatic biliary strictures after liver transplantation.
Nishida S; Nakamura N; Kadono J; Komokata T; Sakata R; Madariaga JR; Tzakis AG
J Hepatobiliary Pancreat Surg; 2006; 13(6):511-6. PubMed ID: 17139424
[TBL] [Abstract][Full Text] [Related]
32. Development of the bile ducts: essentials for the clinical hepatologist.
Strazzabosco M; Fabris L
J Hepatol; 2012 May; 56(5):1159-1170. PubMed ID: 22245898
[TBL] [Abstract][Full Text] [Related]
33. Distribution of apoptotic cells and expression of apoptosis-related proteins along the intrahepatic biliary tree in normal and non-biliary diseased liver.
Harada K; Iwata M; Kono N; Koda W; Shimonishi T; Nakanuma Y
Histopathology; 2000 Oct; 37(4):347-54. PubMed ID: 11012742
[TBL] [Abstract][Full Text] [Related]
34. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis.
Ludwig J; MacCarty RL; LaRusso NF; Krom RA; Wiesner RH
Hepatology; 1986; 6(4):560-8. PubMed ID: 3525365
[TBL] [Abstract][Full Text] [Related]
35. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply.
Nakanuma Y; Hoso M; Sanzen T; Sasaki M
Microsc Res Tech; 1997 Sep; 38(6):552-70. PubMed ID: 9330346
[TBL] [Abstract][Full Text] [Related]
36. Biliary innate immunity in the pathogenesis of biliary diseases.
Harada K; Nakanuma Y
Inflamm Allergy Drug Targets; 2010 Jun; 9(2):83-90. PubMed ID: 20402650
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study on bile ductular proliferation in various hepatobiliary diseases.
Nakanuma Y; Ohta G
Liver; 1986 Aug; 6(4):205-11. PubMed ID: 2430163
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of intrahepatic bile duct component in normal adult human liver and in primary biliary cirrhosis.
Casali AM; Siringo S; Sofia S; Bolondi L; Di Febo G; Cavalli G
Pathol Res Pract; 1994 Feb; 190(2):201-6. PubMed ID: 8058574
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?
Lerut J; Demetris AJ; Stieber AC; Marsh JW; Gordon RD; Esquivel CO; Iwatsuki S; Starzl TE
Transpl Int; 1988 Oct; 1(3):127-30. PubMed ID: 3075471
[TBL] [Abstract][Full Text] [Related]
40. Cholangiocyte pathobiology.
Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
